Huashan Hospital
Clinical trials sponsored by Huashan Hospital, explained in plain language.
-
Multiple sclerosis CAR-T trial pulled before it even started
Disease control TerminatedThis early-stage study aimed to test a single infusion of GC012F CAR-T cells in people with multiple sclerosis. The goal was to check safety and see if the treatment could control the disease. However, the trial was withdrawn before enrolling any participants, so no data was coll…
Phase: EARLY_PHASE1 • Sponsor: Huashan Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:02 UTC
-
New hope for Drug-Resistant TB: a 6-Month pill regimen
Disease control OngoingThis phase 3 trial is testing a 6-month, all-oral combination of four drugs (bedaquiline, delamanid, linezolid, and levofloxacin or clofazimine) to treat rifampin-resistant tuberculosis in Chinese teenagers and adults aged 12 and older. The goal is to see if this shorter regimen …
Phase: PHASE3 • Sponsor: Huashan Hospital • Aim: Disease control
Last updated Jun 26, 2026 13:02 UTC
-
New study tracks how DM1 affects chinese patients over time
Knowledge-focused ENROLLING_BY_INVITATIONThis study follows 1000 Chinese patients with myotonic dystrophy type 1 (DM1) to understand how the disease affects multiple body systems and leads to disability. Researchers will collect health data and blood samples every 3 to 6 months for several years. The goal is to identify…
Sponsor: Huashan Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:00 UTC
-
Can personalized nutrition slow kidney decline? new study investigates
Knowledge-focused ENROLLING_BY_INVITATIONThis study follows 1,800 adults with reduced kidney function (not on dialysis) to see how nutrition and lifestyle affect their health. Researchers will track changes in kidney function, heart health, bone health, and thinking skills over time. The goal is to find better ways to m…
Sponsor: Huashan Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:00 UTC